The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients

The role of soluble soluble urokinase-type plasminogen activator receptor (suPAR) as a biological marker for TB treatment efficacy on active pulmonary TB-AFB(+) patients was investigated. Twenty pulmonary TB-AFB(+) patients participated in a cohort study for six months. The plasma suPAR level was me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mardining Raras, Tri Yudani, Noor Chozin, Iin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335589/
https://www.ncbi.nlm.nih.gov/pubmed/22567258
http://dx.doi.org/10.1155/2010/406346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335589/
https://www.ncbi.nlm.nih.gov/pubmed/22567258
http://dx.doi.org/10.1155/2010/406346

Ejemplares similares